Group 1 - Butterfly Network Inc. (NYSE:BFLY) is recognized as one of the 11 most popular AI penny stocks, with TD Cowen raising its price target to $6 from $4.50, indicating over 64% upside potential [1][2] - The company reported Q4 revenue of $31.5 million, reflecting a 41% year-over-year growth compared to $22.4 million last year, showcasing strategic progress [3][4] - Butterfly Network is transitioning from a medical device company to a semiconductor-based company focused on AI-native imaging, expanding its enterprise adoption and commercializing new applications [4][5] Group 2 - Butterfly Embedded is expected to become a significant revenue stream alongside the core POCUS business, potentially positioning the company as a tech player rather than solely a medical technology business [2][4] - The company offers innovative ultrasound imaging solutions through devices like Butterfly iQ+ and iQ3, along with other products such as Butterfly Move and Compass AI [5]

Financial Data and Key Metrics Changes - Fourth quarter revenues reached $31.5 million, a 41% year-over-year increase, marking the highest quarterly result in the company's history [5][17] - Positive operating cash flow was achieved for the first time, driven by upfront payments from the Midjourney deal [5] - Adjusted EBITDA loss improved to $3.2 million in Q4 2025 from a loss of $9.1 million in Q4 2024, reflecting a 65% improvement [23] - Full year 2025 total revenue increased by 19% to $97.6 million compared to 2024 [21] Business Line Data and Key Metrics Changes - Core POCUS revenue grew 15% year-over-year, following a record 35% growth in the previous year [9] - Butterfly Embedded revenue significantly contributed to the overall growth, particularly from the Midjourney partnership [18][21] - Product revenue was $18.1 million, a 23% increase year-over-year, while software and other services revenue was $13.4 million, up 76% year-over-year [20][21] Market Data and Key Metrics Changes - U.S. revenue was $26.8 million, a 55% increase year-over-year, driven by strong demand in the core business and Butterfly Embedded [19] - International revenue decreased by 6% year-over-year to $4.7 million, with iQ3 sales up 42% but iQ+ sales down 79% [19] Company Strategy and Development Direction - The company aims to strengthen its core franchise and expand its semiconductor ultrasound platform beyond handheld devices [5][8] - The strategic growth plan includes three core tenets: accelerating the core POCUS business, executing strategic initiatives for new care settings, and delivering an R&D roadmap for next-generation chips [8][12] - The Midjourney partnership is seen as a foundational step towards transforming Butterfly into a platform company [13][14] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in macro trends and deal cycles, expecting to carry momentum into 2026 [9] - The company anticipates nominal revenue from home care in 2026, with significant growth potential starting in 2027 [49][52] - The overall outlook for 2026 is positive, with expected revenue growth of 20% to 24% [27][28] Other Important Information - The company achieved a cash and cash equivalent balance of $154.5 million at year-end, with a cash use improvement of $26.4 million compared to 2024 [24] - The company is focused on expanding its home care business and enhancing its AI capabilities through the Compass AI initiative [25][30] Q&A Session Summary Question: Can you provide details on the timing of the technology offering from Midjourney? - Management indicated that something is expected from Midjourney in the near term, emphasizing their role as enablers for partners [38][39] Question: What is the revenue opportunity for the home care franchise? - Management believes the home care business could represent a $40 million-$50 million revenue opportunity if successful [50][51] Question: How is the macro environment affecting the company? - Management noted improved confidence in the macro environment, with some downward pressure from tariffs but overall positive trends [56][57] Question: What is the outlook for partnerships with medical schools? - Management expects strong contributions from medical schools in 2026, as students increasingly seek ultrasound training [59][61]

Financial Data and Key Metrics Changes - The fourth quarter revenues reached $31.5 million, representing a 41% year-over-year growth, marking the highest quarterly result in the company's history [5][18] - Positive operating cash flow was achieved for the first time, driven by upfront payments from the Midjourney deal [5] - Adjusted EBITDA loss improved to $3.2 million in Q4 2025 from a loss of $9.1 million in Q4 2024, reflecting a 65% improvement [24] - Full year 2025 total revenue increased by 19% to $97.6 million compared to 2024 [21] Business Line Data and Key Metrics Changes - Core POCUS revenue grew 15% year-over-year, building on a 35% growth in the previous year [9] - Butterfly Embedded revenue significantly contributed to the overall growth, particularly from the Midjourney partnership [19][22] - Product revenue was $18.1 million, a 23% increase year-over-year, while software and other services revenue surged 76% to $13.4 million [20][21] Market Data and Key Metrics Changes - U.S. revenue was $26.8 million, a 55% increase year-over-year, driven by strong demand in the core business [20] - International revenue decreased by 6% year-over-year to $4.7 million, with a notable 42% increase in iQ3 sales but a 79% decline in iQ+ sales [20] Company Strategy and Development Direction - The company aims to revolutionize imaging with digital ultrasound technology, focusing on expanding its core POCUS business and developing new applications in home care and Ultrasound-on-Chip co-development [7][8] - The strategic growth plan introduced in early 2024 emphasizes financial discipline and unlocking the full value of the semiconductor ultrasound platform [5][6] - The Midjourney partnership is seen as a foundational step towards transforming Butterfly into a platform company, with expectations of significant revenue opportunities in the future [13][14] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in macro trends and deal cycles, expecting to carry momentum into 2026 [9] - The company is well-positioned to leverage its core platform into new markets, with a focus on operational efficiency and ROI [17][26] - Guidance for Q1 2026 anticipates revenue between $24 million and $28 million, with full year 2026 revenue expected to be between $117 million and $121 million, reflecting a 20%-24% increase [27][28] Other Important Information - The company achieved significant milestones in cloud infrastructure security, including GovRAMP and TXRAMP certifications, with FedRAMP anticipated soon [10] - The proprietary beam steering API is set to be released, enhancing 3D imaging capabilities and expanding the AI ecosystem [11] Q&A Session Summary Question: Details on the Midjourney partnership and revenue contributions - Management indicated that Midjourney is expected to provide contributions in the near term, with a $74 million contract that includes various revenue components [41][42] Question: Progress on the home care franchise - Management is confident about reaching a commercial agreement in 2026, with potential revenue opportunities estimated at $40 million-$50 million if the use case becomes national [49][50] Question: Insights on the macro environment and medical school partnerships - Management noted improved confidence in the macro environment and highlighted the strong commitment from medical students to learn ultrasound, which is expected to positively impact sales [56][60]

Financial Performance - Revenue for Q1 2025 reached $21.2 million, a 20% increase compared to $17.7 million in Q1 2024[10] - Gross margin improved to 63%, up 4.8 percentage points from 58.2% in Q1 2024[10] - Operating expenses decreased by 3% from $32.9 million to $31.8 million[10] - Adjusted EBITDA loss improved by 31%, from $(13.2) million to $(9.1) million[10] - Cash and cash equivalents increased to $155.2 million, up from $88.8 million[10] - The company reaffirmed its 2025 revenue guidance of $96 - $100 million, representing approximately 20% growth, and an EBITDA loss of $37 - $42 million[11] Business Updates - The company is focused on medical education, hospital systems, and international expansion within its core POCUS business[6,7,8] - Butterfly signed 5 partners in the portfolio and has over 25 prospects in the pipeline[14] - Two new partners were signed in Q1, bringing the total to 23 portfolio companies, with the first partners on track to commercialize FDA-cleared apps this year[17] - Butterfly HomeCare is piloting virtual chronic care management with a leading Medicare Advantage provider, showing early results with no rehospitalizations for patients with congestive heart failure[22]

Financial Data and Key Metrics Changes - In 2024, Butterfly Network reported revenue of $82.1 million, representing a 25% increase year-over-year, while adjusted EBITDA loss improved by 42% to $38.9 million [9][43][49] - The fourth quarter of 2024 saw revenue of $22.4 million, the highest quarterly result in the company's history, marking a 35% increase compared to the prior year [38][39] - Gross profit for Q4 2024 was $13.7 million, a 45% increase from the prior year, with gross profit margin rising to 61% from 57% [42] Business Line Data and Key Metrics Changes - Product revenue in Q4 2024 was $14.7 million, up 45% year-over-year, driven by higher average selling prices and volume [40] - Software and other services revenue reached $7.6 million in Q4 2024, a 20% increase compared to the prior year, although the mix decreased by approximately four percentage points [40] Market Data and Key Metrics Changes - U.S. revenue in Q4 2024 was $14.5 million, a 32% increase year-over-year, while international revenue increased by 19% to $5.5 million [39] - The launch of the iQ3 device accounted for 50% of overall sales in units and 58% of probe revenue in 2024 [13] Company Strategy and Development Direction - Butterfly Network aims to expand its digital ecosystem and enhance accessibility to ultrasound technology, targeting a vision where every healthcare provider has a personal imaging device [10][11] - The company is focusing on scaling its core POCUS business and expanding into new markets, including home care and veterinary applications [22][23][29] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving a revenue target of $96 million to $100 million for 2025, representing approximately 20% growth, while maintaining fiscal discipline [49] - The company is optimistic about the potential of its HomeCare and Octiv businesses, which are expected to contribute significantly to future revenue [66][68] Other Important Information - Butterfly Network raised $81.7 million from a follow-on offering in January 2025, providing a bridge to cash flow independence [48] - The company has signed 21 partners in its Butterfly Garden initiative, with six expected to go commercial in 2025 [24] Q&A Session Summary Question: Update on confidence level for $500 million revenue target - Management is bullish about growth initiatives and believes they are on track to achieve the long-term revenue target [62][64] Question: Steps required to transition HomeCare from pilot to revenue - The transition involves training on-site personnel and utilizing telemedicine for scalability, with a 90-day process for training [75][79] Question: Update on wearable technology development - The wearable is in development, with a focus on building market demand before launching the product [88][90] Question: Details on HomeCare pilot and patient involvement - 18 nurses were trained across two facilities, with a pilot designed for 200 patients, and no readmissions reported so far [92][95] Question: Hardware developments and iQ station update - The company is actively working on next-generation hardware and the iQ station, which will expand into the lower-end cart business [97][100]

Financial Data and Key Metrics Changes - In 2024, Butterfly Network reported revenue of $82.1 million, representing a 25% increase year-over-year, while adjusted EBITDA loss improved by 42% to $38.9 million [9][43] - The fourth quarter of 2024 saw revenue of $22.4 million, the highest quarterly result in the company's history, marking a 35% increase compared to the prior year [38] - Gross profit for Q4 2024 was $13.7 million, a 45% increase from the prior year, with gross profit margin rising to 61% from 57% [42] Business Line Data and Key Metrics Changes - The iQ3 product accounted for 50% of overall sales in units and 58% of probe revenue in 2024, with higher average selling prices compared to previous devices [13] - Product revenue in Q4 2024 was $14.7 million, a 45% increase year-over-year, while software and other services revenue was $7.6 million, up 20% [40] - Total annual recurring revenue grew slightly, led by an 8% increase in enterprise software subscription ARR [41] Market Data and Key Metrics Changes - U.S. revenue in Q4 2024 was $14.5 million, a 32% increase from the prior year, driven by higher average selling prices and strong demand [39] - International revenue increased by 19% year-over-year to $5.5 million, driven by higher probe volume [39] - The company received EU MDR for iQ+ and iQ3, facilitating access to new markets in Europe and Asia [18] Company Strategy and Development Direction - Butterfly Network aims to expand its digital ecosystem and enhance accessibility to ultrasound technology, targeting a vision where every healthcare provider has a personal imaging device [10] - The company is focusing on scaling its core POCUS business and developing software improvements for data management workflows [22] - Strategic initiatives include expanding partnerships within the Butterfly Garden and commercializing chip technology through Octiv [23][28] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving long-term growth targets, emphasizing the importance of the HomeCare and Octiv businesses as significant growth drivers [62][66] - The company plans to maintain fiscal discipline while investing in growth initiatives, projecting 2025 revenue of $96 million to $100 million, representing approximately 20% growth [49] - Management highlighted the successful pilot programs in HomeCare, indicating potential for significant cost savings and improved patient care [31][34] Other Important Information - Butterfly Network raised $81.7 million from a follow-on offering in January 2025, providing a bridge to cash flow independence [48] - The company is actively developing a wearable ultrasound device, with plans to integrate it into the HomeCare model as market demand grows [88][90] Q&A Session Summary Question: Update on confidence level for reaching $500 million revenue target - Management is bullish about growth initiatives and believes they are on track to achieve long-term revenue goals, particularly in the core business and new areas like Octiv and HomeCare [62][64] Question: Steps required to transition HomeCare from pilot to revenue-generating franchise - The transition involves training on-site personnel and utilizing telemedicine for scalability, with a 90-day process for training expected [75][79] Question: Update on wearable ultrasound program - The wearable device is in development, with a focus on building market demand before launching the product [88][90] Question: Details on HomeCare pilot and patient involvement - The pilot involves training 18 nurses across two facilities, with an initial target of 200 patients, and no readmissions reported so far [92][95] Question: Hardware developments and iQ station update - The company is working on next-generation hardware and the iQ station, which will expand into the lower-end cart business [97][99] Question: Clarification on revenue guidance - The 2025 revenue guidance does not include new revenue streams from Octiv or HomeCare, only existing contracts [104][105]